ADAMTS13 and COVID-19: Increased levels of vWf, Ang-II, and P-selectin and a decreased activity of Willebrand factor-cleaving protease (VWFCP, ADAMTS-13) further highlight endothelial activation in critically ill patients with COVID-19 [154].